Menu
Not yet recruiting NCT06616103

Quantitative CT Imaging Parameters for Assessing Hepatic Steatosis in CHB

— Observational Chronic Hepatitis B Steatosis of Liver Fibrosis and Cirrhosis of Liver

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: computerized tomography.
Who it may be relevant to
Registry conditions: Chronic Hepatitis B, Steatosis of Liver, Fibrosis and Cirrhosis of Liver. Basic parameters: from 19 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
South Korea
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Utility of Quantitative Imaging Parameters from Deep Learning-based CT Segmentation in Assessing Hepatic Steatosis and Fibrosis in Chronic Hepatitis B: a Prospective Study Using MRI As the Reference Standard

Overview

This study aims to evaluate diagnostic performance of CT attenuation parameters acquired using deep learning algorithm in assessing hepatic steatosis and fibrosis.

Interventions

  • Diagnostic test computerized tomography
    noncontrast abdominal CT

Primary outcome measures

  • diagnostic performance of CT attenuatio parameters in assessing hepatic steatosis and fibrosis [Time frame: At the time of enrollment]
Secondary outcome measures (1)
  • Consistency between MRI-derived body composition data and CT-derived data [Time frame: At the time of enrollment]

Eligibility criteria

Inclusion criteria

  • chronic hepatitis B
  • no chronic liver disease other than chronic hepatitis B
  • Body mass index \>= 23

Exclusion criteria

  • pregnant women
  • unable to perform MRI examinations due to claustrophobia or metallic foreign body
  • suspicious hepatic malignancy on previous imaging studies
  • history of local treatment for hepatic lesions
  • history of surgery or catheter insertion of liver or spleen

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

South Korea · 1 center
  • Seoul National University Hospital — Seoul

Identifiers

NCT: NCT06616103 · CHB prospective MEDIP · RS-2023-00253896

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗